Ventavis Adverse Event Report 2018


This report includes data from the FDA’s Adverse Events Reports for 2018.  We removed reports where the subject of the report was taking only this drug. This report provides the following fields:

  • ID
  • Patient Summary
  • Patient Gender
  • Patient Age
  • Drug Products
  • Drug Reactions


Ventavis (iloprost) is an synthetic prostacyclin. It works by opening blood vessels in the lungs. Ventavis inhalation is used to treat pulmonary arterial hypertension (PAH). It decreases symptoms of this condition and improves your ability to exercise. Ventavis may also be used for purposes not listed in this medication guide.